JP6577569B2 - C−アリールグリコシド誘導体、その薬物組成物、及び調製方法 - Google Patents
C−アリールグリコシド誘導体、その薬物組成物、及び調製方法 Download PDFInfo
- Publication number
- JP6577569B2 JP6577569B2 JP2017505695A JP2017505695A JP6577569B2 JP 6577569 B2 JP6577569 B2 JP 6577569B2 JP 2017505695 A JP2017505695 A JP 2017505695A JP 2017505695 A JP2017505695 A JP 2017505695A JP 6577569 B2 JP6577569 B2 JP 6577569B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvent
- mmol
- reaction
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 52
- 239000000203 mixture Substances 0.000 title claims description 39
- 229930182470 glycoside Natural products 0.000 title claims description 31
- 239000003814 drug Substances 0.000 title claims description 29
- 229940079593 drug Drugs 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 207
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 176
- 238000006243 chemical reaction Methods 0.000 claims description 169
- 239000002904 solvent Substances 0.000 claims description 113
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 98
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 72
- 238000000034 method Methods 0.000 claims description 65
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 64
- -1 aryl glycoside Chemical class 0.000 claims description 64
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 36
- 229910052799 carbon Inorganic materials 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 26
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 26
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 claims description 24
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- 229910052760 oxygen Inorganic materials 0.000 claims description 21
- 125000006239 protecting group Chemical group 0.000 claims description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 18
- 239000003513 alkali Substances 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 239000008103 glucose Substances 0.000 claims description 18
- 229910052736 halogen Inorganic materials 0.000 claims description 17
- 150000002367 halogens Chemical class 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 229910015900 BF3 Inorganic materials 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 13
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- 229940124597 therapeutic agent Drugs 0.000 claims description 11
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 10
- 230000009471 action Effects 0.000 claims description 10
- 239000000460 chlorine Substances 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 239000012046 mixed solvent Substances 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 238000001953 recrystallisation Methods 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 238000006722 reduction reaction Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 206010012601 diabetes mellitus Diseases 0.000 claims description 6
- 229940127003 anti-diabetic drug Drugs 0.000 claims description 5
- 239000003472 antidiabetic agent Substances 0.000 claims description 5
- 125000001246 bromo group Chemical group Br* 0.000 claims description 5
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 5
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 claims description 5
- 208000002249 Diabetes Complications Diseases 0.000 claims description 4
- 206010012655 Diabetic complications Diseases 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 125000002346 iodo group Chemical group I* 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 4
- 235000020824 obesity Nutrition 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 238000006751 Mitsunobu reaction Methods 0.000 claims description 3
- 229910052740 iodine Chemical group 0.000 claims description 3
- 239000011630 iodine Chemical group 0.000 claims description 3
- 208000030159 metabolic disease Diseases 0.000 claims description 3
- 125000001979 organolithium group Chemical group 0.000 claims description 3
- 102000000070 Sodium-Glucose Transport Proteins Human genes 0.000 claims description 2
- 108010080361 Sodium-Glucose Transport Proteins Proteins 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229940121377 sodium-glucose co-transporter inhibitor Drugs 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 230000000155 isotopic effect Effects 0.000 claims 5
- 238000006467 substitution reaction Methods 0.000 claims 5
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 125000006165 cyclic alkyl group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 222
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 111
- 239000000243 solution Substances 0.000 description 74
- 238000005481 NMR spectroscopy Methods 0.000 description 73
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 43
- 239000012074 organic phase Substances 0.000 description 43
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 38
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- 239000003208 petroleum Substances 0.000 description 33
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 32
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 31
- 238000010898 silica gel chromatography Methods 0.000 description 29
- 239000007787 solid Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 230000015572 biosynthetic process Effects 0.000 description 26
- 238000003786 synthesis reaction Methods 0.000 description 26
- 238000004458 analytical method Methods 0.000 description 23
- 125000000753 cycloalkyl group Chemical group 0.000 description 23
- 239000012043 crude product Substances 0.000 description 22
- 239000010410 layer Substances 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 20
- 239000011734 sodium Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 17
- 238000010791 quenching Methods 0.000 description 17
- 238000002390 rotary evaporation Methods 0.000 description 17
- 238000004821 distillation Methods 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 229920006395 saturated elastomer Polymers 0.000 description 15
- 238000001308 synthesis method Methods 0.000 description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 12
- 125000002619 bicyclic group Chemical group 0.000 description 12
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 230000000171 quenching effect Effects 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- 238000000746 purification Methods 0.000 description 11
- 125000001072 heteroaryl group Chemical group 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical group CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000002194 synthesizing effect Effects 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 239000012279 sodium borohydride Substances 0.000 description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 6
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 6
- 229940007550 benzyl acetate Drugs 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 125000004438 haloalkoxy group Chemical group 0.000 description 6
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 229940002612 prodrug Drugs 0.000 description 6
- 239000000651 prodrug Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- DPIALHFJIMHDAS-RUPQSZEGSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-RUPQSZEGSA-N 0.000 description 5
- DPIALHFJIMHDAS-RIVXRUHVSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-RIVXRUHVSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 5
- 125000003282 alkyl amino group Chemical group 0.000 description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- DPIALHFJIMHDAS-QYENANPWSA-N (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2,3-dihydro-1-benzofuran-2-ylmethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-QYENANPWSA-N 0.000 description 4
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 4
- NNQDMQVWOWCVEM-UHFFFAOYSA-N 1-bromoprop-1-ene Chemical compound CC=CBr NNQDMQVWOWCVEM-UHFFFAOYSA-N 0.000 description 4
- RRUIKDIGARKZIA-UHFFFAOYSA-N 3-fluoro-2-prop-2-enylphenol Chemical compound OC1=CC=CC(F)=C1CC=C RRUIKDIGARKZIA-UHFFFAOYSA-N 0.000 description 4
- BLKGHTVOWGHABE-KGFFULNXSA-N C1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound C1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 BLKGHTVOWGHABE-KGFFULNXSA-N 0.000 description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 4
- ICPXVOYHMMUINK-AARQZCDPSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1(OC2=C(C1)C=CC=C2)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1(OC2=C(C1)C=CC=C2)C ICPXVOYHMMUINK-AARQZCDPSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 4
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 4
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 description 4
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 4
- 229960003345 empagliflozin Drugs 0.000 description 4
- OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 description 4
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical class [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- QYFBYHXEEODTMX-QMMMGPOBSA-N (2S)-2-(bromomethyl)-2,3-dihydro-1-benzofuran Chemical compound BrC[C@H]1OC2=C(C1)C=CC=C2 QYFBYHXEEODTMX-QMMMGPOBSA-N 0.000 description 3
- CJBNUOVCABHNLY-NSDXNHJYSA-N (2S,3R,4R,5S,6S)-2-[4-chloro-3-[[4-[(7-fluoro-2,3-dihydro-1-benzofuran-2-yl)methoxy]phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F CJBNUOVCABHNLY-NSDXNHJYSA-N 0.000 description 3
- KIMJBSWICNBTOJ-UHFFFAOYSA-N (3,3-dimethyl-1h-2-benzofuran-1-yl)methanol Chemical compound C1=CC=C2C(C)(C)OC(CO)C2=C1 KIMJBSWICNBTOJ-UHFFFAOYSA-N 0.000 description 3
- VFXRFXAEZVQAHB-UHFFFAOYSA-N (5-fluoro-1-benzofuran-2-yl)methanol Chemical compound FC1=CC=C2OC(CO)=CC2=C1 VFXRFXAEZVQAHB-UHFFFAOYSA-N 0.000 description 3
- UWOCHNNRMCCPTF-UHFFFAOYSA-N (7-fluoro-2,3-dihydro-1-benzofuran-2-yl)methanol Chemical compound C1=CC(F)=C2OC(CO)CC2=C1 UWOCHNNRMCCPTF-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- OKTWLGWQEYGNBA-UHFFFAOYSA-N 1,3-dihydro-2-benzofuran-1-ylmethanol Chemical compound C1=CC=C2C(CO)OCC2=C1 OKTWLGWQEYGNBA-UHFFFAOYSA-N 0.000 description 3
- MABBMHBZKPIFFV-UHFFFAOYSA-N 1-fluoro-2-prop-2-enoxybenzene Chemical compound FC1=CC=CC=C1OCC=C MABBMHBZKPIFFV-UHFFFAOYSA-N 0.000 description 3
- WTUUABQVRKOWKA-UHFFFAOYSA-N 1-fluoro-3-prop-2-enoxybenzene Chemical compound FC1=CC=CC(OCC=C)=C1 WTUUABQVRKOWKA-UHFFFAOYSA-N 0.000 description 3
- WDZLZKSUBSXWID-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-2-ol Chemical compound C1=CC=C2OC(O)CC2=C1 WDZLZKSUBSXWID-UHFFFAOYSA-N 0.000 description 3
- ADDZHRRCUWNSCS-UHFFFAOYSA-N 2-Benzofurancarboxaldehyde Chemical compound C1=CC=C2OC(C=O)=CC2=C1 ADDZHRRCUWNSCS-UHFFFAOYSA-N 0.000 description 3
- FDUBQNUDZOGOFE-UHFFFAOYSA-N 5-fluoro-2-hydroxybenzaldehyde Chemical compound OC1=CC=C(F)C=C1C=O FDUBQNUDZOGOFE-UHFFFAOYSA-N 0.000 description 3
- WUNQTXVVERFOSK-UHFFFAOYSA-N 5-fluoro-2-prop-2-enylphenol Chemical compound OC1=CC(F)=CC=C1CC=C WUNQTXVVERFOSK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- VLQIGOKMXCJNAM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4F)C=C2)C=1)Cl VLQIGOKMXCJNAM-UHFFFAOYSA-N 0.000 description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 3
- NIEOGUOGNSNLAX-UHFFFAOYSA-N CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)OC Chemical compound CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)OC NIEOGUOGNSNLAX-UHFFFAOYSA-N 0.000 description 3
- AQRNSHVFGHMMFJ-XUZJJRAFSA-N CC1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound CC1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 AQRNSHVFGHMMFJ-XUZJJRAFSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- KTGWASGADVZXKH-WGWDPUIZSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OCC2=CC=CC=C12 KTGWASGADVZXKH-WGWDPUIZSA-N 0.000 description 3
- IFZLNUZUEFXQRL-VQYGVQKLSA-N O1[C@@H](CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1[C@@H](CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 IFZLNUZUEFXQRL-VQYGVQKLSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- OKTWLGWQEYGNBA-VIFPVBQESA-N [C@H]1(OCC2=CC=CC=C12)CO Chemical compound [C@H]1(OCC2=CC=CC=C12)CO OKTWLGWQEYGNBA-VIFPVBQESA-N 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- RBQUPHUYCPBKSF-UHFFFAOYSA-N ethyl 5-fluoro-1-benzofuran-2-carboxylate Chemical compound FC1=CC=C2OC(C(=O)OCC)=CC2=C1 RBQUPHUYCPBKSF-UHFFFAOYSA-N 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical group [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 3
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 description 3
- 125000006574 non-aromatic ring group Chemical group 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 3
- XBPDGDITBHGBNK-MRXNPFEDSA-N (2R)-1-(2-methoxyphenyl)-3-phenylmethoxypropan-2-ol Chemical compound C(C1=CC=CC=C1)OC[C@@H](CC1=C(C=CC=C1)OC)O XBPDGDITBHGBNK-MRXNPFEDSA-N 0.000 description 2
- QYFBYHXEEODTMX-MRVPVSSYSA-N (2r)-2-(bromomethyl)-2,3-dihydro-1-benzofuran Chemical compound C1=CC=C2O[C@@H](CBr)CC2=C1 QYFBYHXEEODTMX-MRVPVSSYSA-N 0.000 description 2
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 2
- OEURLNJEQCLGPS-UHFFFAOYSA-N (5-bromo-2-chlorophenyl)-(4-ethoxyphenyl)methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)C1=CC(Br)=CC=C1Cl OEURLNJEQCLGPS-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- YUCBLVFHJWOYDN-HVLQGHBFSA-N 1,4-bis[(s)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]phthalazine Chemical compound C1=C(OC)C=C2C([C@H](OC=3C4=CC=CC=C4C(O[C@H]([C@@H]4N5CC[C@H]([C@H](C5)CC)C4)C=4C5=CC(OC)=CC=C5N=CC=4)=NN=3)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 YUCBLVFHJWOYDN-HVLQGHBFSA-N 0.000 description 2
- HSOMHPHYGAQRTF-UHFFFAOYSA-N 1-benzofuran-2-ylmethanol Chemical compound C1=CC=C2OC(CO)=CC2=C1 HSOMHPHYGAQRTF-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- NTYPQDZCDDLKLV-UHFFFAOYSA-N 1-bromo-2-prop-2-enylbenzene Chemical compound BrC1=CC=CC=C1CC=C NTYPQDZCDDLKLV-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- ZJMQZZXXIOGDIO-UHFFFAOYSA-N 2-(2,3-dihydro-1-benzofuran-2-yl)ethanol Chemical compound C1=CC=C2OC(CCO)CC2=C1 ZJMQZZXXIOGDIO-UHFFFAOYSA-N 0.000 description 2
- LSGCBNJHZGJEEJ-UHFFFAOYSA-N 2-(chloromethyl)-1-benzofuran Chemical compound C1=CC=C2OC(CCl)=CC2=C1 LSGCBNJHZGJEEJ-UHFFFAOYSA-N 0.000 description 2
- IWFBKDZCZVDZRT-UHFFFAOYSA-N 2-(chloromethyl)-5-fluoro-1-benzofuran Chemical compound FC1=CC=C2OC(CCl)=CC2=C1 IWFBKDZCZVDZRT-UHFFFAOYSA-N 0.000 description 2
- DHXICAQGITWFAS-VIFPVBQESA-N 2-[(3R)-3-bromo-3-hydroxypropyl]phenol Chemical compound Br[C@H](CCC1=C(C=CC=C1)O)O DHXICAQGITWFAS-VIFPVBQESA-N 0.000 description 2
- DHEJIZSVHGOKMJ-UHFFFAOYSA-N 2-ethenylbenzaldehyde Chemical compound C=CC1=CC=CC=C1C=O DHEJIZSVHGOKMJ-UHFFFAOYSA-N 0.000 description 2
- FZIBGCDUHZBOLA-UHFFFAOYSA-N 2-fluoro-6-hydroxybenzaldehyde Chemical compound OC1=CC=CC(F)=C1C=O FZIBGCDUHZBOLA-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- SJTBRFHBXDZMPS-UHFFFAOYSA-N 3-fluorophenol Chemical compound OC1=CC=CC(F)=C1 SJTBRFHBXDZMPS-UHFFFAOYSA-N 0.000 description 2
- KULJEMKFHPLNBR-UHFFFAOYSA-N 4-[(7-fluoro-2,3-dihydro-1-benzofuran-2-yl)methoxy]benzaldehyde Chemical compound FC1=CC=CC=2CC(OC=21)COC1=CC=C(C=C1)C=O KULJEMKFHPLNBR-UHFFFAOYSA-N 0.000 description 2
- YUCBLVFHJWOYDN-PPIALRKJSA-N 4-[(r)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]-1-[(r)-[(2r,4r,5s)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]phthalazine Chemical compound C1=C(OC)C=C2C([C@@H](OC=3C4=CC=CC=C4C(O[C@@H]([C@@H]4N5CC[C@@H]([C@@H](C5)CC)C4)C=4C5=CC(OC)=CC=C5N=CC=4)=NN=3)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 YUCBLVFHJWOYDN-PPIALRKJSA-N 0.000 description 2
- ZUNCHZBITMUSRD-UHFFFAOYSA-N 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1Cl ZUNCHZBITMUSRD-UHFFFAOYSA-N 0.000 description 2
- GBJJCODOZGPTBC-UHFFFAOYSA-N 4-fluoro-2-hydroxybenzaldehyde Chemical compound OC1=CC(F)=CC=C1C=O GBJJCODOZGPTBC-UHFFFAOYSA-N 0.000 description 2
- HELBBGLIOALLAF-UHFFFAOYSA-N 5-bromo-2-cyanobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1C#N HELBBGLIOALLAF-UHFFFAOYSA-N 0.000 description 2
- JFDUXZIRWBYBAQ-UHFFFAOYSA-N 5-bromo-2-methoxybenzoic acid Chemical compound COC1=CC=C(Br)C=C1C(O)=O JFDUXZIRWBYBAQ-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 229910001148 Al-Li alloy Inorganic materials 0.000 description 2
- JZUIPNJQQBHLQR-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 Chemical compound BrC1=CC(=C(C#N)C=C1)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 JZUIPNJQQBHLQR-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- RKGGXOVYJOETLH-GOSISDBHSA-N CC(C)[Si](C(C)C)(C(C)C)OC[C@@H]1C2=CC=CC=C2CO1 Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC[C@@H]1C2=CC=CC=C2CO1 RKGGXOVYJOETLH-GOSISDBHSA-N 0.000 description 2
- WHYIFGGVIVRJAM-UHFFFAOYSA-N CC1(OCC2=CC=CC=C12)CO Chemical compound CC1(OCC2=CC=CC=C12)CO WHYIFGGVIVRJAM-UHFFFAOYSA-N 0.000 description 2
- XVGIBYTWUNKGFC-SNVBAGLBSA-N CC=1C=C2CO[C@@H](C2=CC=1)CO Chemical compound CC=1C=C2CO[C@@H](C2=CC=1)CO XVGIBYTWUNKGFC-SNVBAGLBSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- CJBNUOVCABHNLY-FMHUMOTFSA-N ClC1=C(C=C(C=C1)C1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F Chemical compound ClC1=C(C=C(C=C1)C1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F CJBNUOVCABHNLY-FMHUMOTFSA-N 0.000 description 2
- DSJFUERPPUSDHY-AARQZCDPSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1(OCC2=CC=CC=C12)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1(OCC2=CC=CC=C12)C DSJFUERPPUSDHY-AARQZCDPSA-N 0.000 description 2
- KTGWASGADVZXKH-JABWBWSPSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OCC2=CC=CC=C12 KTGWASGADVZXKH-JABWBWSPSA-N 0.000 description 2
- KTGWASGADVZXKH-GTMDKHCLSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC=CC=C12 KTGWASGADVZXKH-GTMDKHCLSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- OBWASQILIWPZMG-UHFFFAOYSA-N Empagliflozin Chemical compound OC1C(O)C(O)C(CO)OC1C1=CC=C(Cl)C(CC=2C=CC(OC3COCC3)=CC=2)=C1 OBWASQILIWPZMG-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- VFLMFIMNNIHXQU-SECBINFHSA-N FC=1C=C2CO[C@@H](C2=CC=1)CO Chemical compound FC=1C=C2CO[C@@H](C2=CC=1)CO VFLMFIMNNIHXQU-SECBINFHSA-N 0.000 description 2
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 2
- 108010027279 Facilitative Glucose Transport Proteins Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- OKTWLGWQEYGNBA-SECBINFHSA-N OC[C@H]1OCc2ccccc12 Chemical compound OC[C@H]1OCc2ccccc12 OKTWLGWQEYGNBA-SECBINFHSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- ITMGMSZDAOAVNO-QMMMGPOBSA-N [(2s)-2,3-dihydro-1-benzofuran-2-yl]methanol Chemical compound C1=CC=C2O[C@H](CO)CC2=C1 ITMGMSZDAOAVNO-QMMMGPOBSA-N 0.000 description 2
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 229960001713 canagliflozin Drugs 0.000 description 2
- VHOFTEAWFCUTOS-TUGBYPPCSA-N canagliflozin hydrate Chemical compound O.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 VHOFTEAWFCUTOS-TUGBYPPCSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000004296 chiral HPLC Methods 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 description 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 208000016097 disease of metabolism Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 2
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000012285 osmium tetroxide Substances 0.000 description 2
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 2
- 210000000512 proximal kidney tubule Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 2
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- RDNZYEDFRMEYQF-UHFFFAOYSA-N (2-ethenylphenyl)methyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1C=C RDNZYEDFRMEYQF-UHFFFAOYSA-N 0.000 description 1
- QNYBOILAKBSWFG-JTQLQIEISA-N (2r)-2-(phenylmethoxymethyl)oxirane Chemical compound C([C@@H]1OC1)OCC1=CC=CC=C1 QNYBOILAKBSWFG-JTQLQIEISA-N 0.000 description 1
- YKXCWZVUWWQSAV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O YKXCWZVUWWQSAV-BTVCFUMJSA-N 0.000 description 1
- QNYBOILAKBSWFG-SNVBAGLBSA-N (2s)-2-(phenylmethoxymethyl)oxirane Chemical compound C([C@H]1OC1)OCC1=CC=CC=C1 QNYBOILAKBSWFG-SNVBAGLBSA-N 0.000 description 1
- LVILQFKAGQFQEK-UHFFFAOYSA-N (5-bromo-2-chlorophenyl)-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC(Br)=CC=C1Cl LVILQFKAGQFQEK-UHFFFAOYSA-N 0.000 description 1
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 description 1
- DQXKOHDUMJLXKH-PHEQNACWSA-N (e)-n-[2-[2-[[(e)-oct-2-enoyl]amino]ethyldisulfanyl]ethyl]oct-2-enamide Chemical compound CCCCC\C=C\C(=O)NCCSSCCNC(=O)\C=C\CCCCC DQXKOHDUMJLXKH-PHEQNACWSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- MPCAJMNYNOGXPB-UHFFFAOYSA-N 1,5-anhydrohexitol Chemical compound OCC1OCC(O)C(O)C1O MPCAJMNYNOGXPB-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- PIMNFNXBTGPCIL-UHFFFAOYSA-N 1-(2-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1Br PIMNFNXBTGPCIL-UHFFFAOYSA-N 0.000 description 1
- AZOVTQNTDOPLFQ-UHFFFAOYSA-N 1-[2-(3-bromophenyl)-4-fluorophenyl]ethanone Chemical compound CC(=O)c1ccc(F)cc1-c1cccc(Br)c1 AZOVTQNTDOPLFQ-UHFFFAOYSA-N 0.000 description 1
- NZKWIAVSCANBMU-UHFFFAOYSA-N 1-bromo-3-[(4-ethoxyphenyl)methyl]benzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC=CC(Br)=C1 NZKWIAVSCANBMU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- YJUFGFXVASPYFQ-UHFFFAOYSA-N 2,3-dihydro-1-benzothiophene Chemical compound C1=CC=C2SCCC2=C1 YJUFGFXVASPYFQ-UHFFFAOYSA-N 0.000 description 1
- 125000004564 2,3-dihydrobenzofuran-2-yl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
- GNENVASJJIUNER-UHFFFAOYSA-N 2,4,6-tricyclohexyloxy-1,3,5,2,4,6-trioxatriborinane Chemical compound C1CCCCC1OB1OB(OC2CCCCC2)OB(OC2CCCCC2)O1 GNENVASJJIUNER-UHFFFAOYSA-N 0.000 description 1
- BVCOJESIQPNOIF-UHFFFAOYSA-N 2-(2-bromophenyl)acetonitrile Chemical compound BrC1=CC=CC=C1CC#N BVCOJESIQPNOIF-UHFFFAOYSA-N 0.000 description 1
- WWPKCWFXTQSXKX-UHFFFAOYSA-N 2-[[4-[(5-bromo-2-methoxyphenyl)methyl]phenyl]methyl]-1-benzofuran Chemical compound BrC=1C=CC(=C(CC2=CC=C(C=C2)CC=2OC3=C(C=2)C=CC=C3)C=1)OC WWPKCWFXTQSXKX-UHFFFAOYSA-N 0.000 description 1
- QIRNGVVZBINFMX-UHFFFAOYSA-N 2-allylphenol Chemical compound OC1=CC=CC=C1CC=C QIRNGVVZBINFMX-UHFFFAOYSA-N 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- YKZMHGAKPDCTCH-UHFFFAOYSA-N 2-fluoro-6-(oxan-2-yloxy)benzaldehyde Chemical compound FC1=CC=CC(OC2OCCCC2)=C1C=O YKZMHGAKPDCTCH-UHFFFAOYSA-N 0.000 description 1
- HFHFGHLXUCOHLN-UHFFFAOYSA-N 2-fluorophenol Chemical compound OC1=CC=CC=C1F HFHFGHLXUCOHLN-UHFFFAOYSA-N 0.000 description 1
- FZTDYEUXQXNEER-UHFFFAOYSA-N 2-prop-2-enylbenzaldehyde Chemical compound C=CCC1=CC=CC=C1C=O FZTDYEUXQXNEER-UHFFFAOYSA-N 0.000 description 1
- YRLORWPBJZEGBX-UHFFFAOYSA-N 3,4-dihydro-2h-1,4-benzoxazine Chemical compound C1=CC=C2NCCOC2=C1 YRLORWPBJZEGBX-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- BEYBTNQFCZVLQL-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]-1-fluorobenzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1F BEYBTNQFCZVLQL-UHFFFAOYSA-N 0.000 description 1
- MPOCPHMKKBYZMO-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]-1-methylbenzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1C MPOCPHMKKBYZMO-UHFFFAOYSA-N 0.000 description 1
- WJFJJYNKLXCHHX-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]benzonitrile Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1C#N WJFJJYNKLXCHHX-UHFFFAOYSA-N 0.000 description 1
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- ADKYNRATSQVVPJ-UHFFFAOYSA-N 5,6,7,8,9,10-hexahydrobenzo[8]annulene Chemical compound C1CCCCCC2=CC=CC=C21 ADKYNRATSQVVPJ-UHFFFAOYSA-N 0.000 description 1
- FGERXQWKKIVFQG-UHFFFAOYSA-N 5-bromo-2-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1Cl FGERXQWKKIVFQG-UHFFFAOYSA-N 0.000 description 1
- IJIBRSFAXRFPPN-UHFFFAOYSA-N 5-bromo-2-methoxybenzaldehyde Chemical compound COC1=CC=C(Br)C=C1C=O IJIBRSFAXRFPPN-UHFFFAOYSA-N 0.000 description 1
- HEOQXHNKRXRCTO-UHFFFAOYSA-N 6,7,8,9-tetrahydro-5h-benzo[7]annulene Chemical compound C1CCCCC2=CC=CC=C21 HEOQXHNKRXRCTO-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- GDGHVZJZDZYBPO-UHFFFAOYSA-N BrC1=C(C=CC=C1)CC=C.C(C=C)C1=C(C=O)C=CC=C1 Chemical compound BrC1=C(C=CC=C1)CC=C.C(C=C)C1=C(C=O)C=CC=C1 GDGHVZJZDZYBPO-UHFFFAOYSA-N 0.000 description 1
- POJHBRBRGOROEC-PKLMIRHRSA-N BrC1=C(C=CC=C1)OC.C(C1=CC=CC=C1)OC[C@@H](CC1=C(C=CC=C1)OC)O Chemical compound BrC1=C(C=CC=C1)OC.C(C1=CC=CC=C1)OC[C@@H](CC1=C(C=CC=C1)OC)O POJHBRBRGOROEC-PKLMIRHRSA-N 0.000 description 1
- YCQOIHAKJKSBAV-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)C(C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2)=O.BrC2=CC(=C(C#N)C=C2)C(O)C2=CC=C(C=C2)OCC2OC1=C(C2)C=CC=C1 Chemical compound BrC1=CC(=C(C#N)C=C1)C(C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2)=O.BrC2=CC(=C(C#N)C=C2)C(O)C2=CC=C(C=C2)OCC2OC1=C(C2)C=CC=C1 YCQOIHAKJKSBAV-UHFFFAOYSA-N 0.000 description 1
- PDXDPRVWKFYTEK-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)C(O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2.BrC2=CC(=C(C#N)C=C2)CC2=CC=C(C=C2)OCC2OC1=C(C2)C=CC=C1 Chemical compound BrC1=CC(=C(C#N)C=C1)C(O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2.BrC2=CC(=C(C#N)C=C2)CC2=CC=C(C=C2)OCC2OC1=C(C2)C=CC=C1 PDXDPRVWKFYTEK-UHFFFAOYSA-N 0.000 description 1
- MEQVJPAXGJYBRP-UHFFFAOYSA-N BrC1=CC(=C(C=C1)Cl)CC1=CC(=C(C=C1)OC)F Chemical compound BrC1=CC(=C(C=C1)Cl)CC1=CC(=C(C=C1)OC)F MEQVJPAXGJYBRP-UHFFFAOYSA-N 0.000 description 1
- WBVUGMIGLDKZCG-UHFFFAOYSA-N BrC=1C=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=CC=1 Chemical compound BrC=1C=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=CC=1 WBVUGMIGLDKZCG-UHFFFAOYSA-N 0.000 description 1
- MKEKLDFOAOQVFQ-UHFFFAOYSA-N BrC=1C=CC(=C(C1)C(=O)C1=CC=C(C=C1)OCC)Cl.BrC1=CC(=C(C=C1)Cl)CC1=CC=C(C=C1)OCC Chemical compound BrC=1C=CC(=C(C1)C(=O)C1=CC=C(C=C1)OCC)Cl.BrC1=CC(=C(C=C1)Cl)CC1=CC=C(C=C1)OCC MKEKLDFOAOQVFQ-UHFFFAOYSA-N 0.000 description 1
- IJLICWIHSZYBFU-UHFFFAOYSA-N BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F)Cl Chemical compound BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F)Cl IJLICWIHSZYBFU-UHFFFAOYSA-N 0.000 description 1
- URVJFGYDYKPLBK-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3(OC4=C(C3)C=CC=C4)C)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3(OC4=C(C3)C=CC=C4)C)C=C2)C=1)C URVJFGYDYKPLBK-UHFFFAOYSA-N 0.000 description 1
- DXBBKUCXUCCWDO-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3(OC4=C(C3)C=CC=C4)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3(OC4=C(C3)C=CC=C4)C)C=C2)C=1)Cl DXBBKUCXUCCWDO-UHFFFAOYSA-N 0.000 description 1
- CWJZWCRVEWUZAG-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3(OCC4=CC=CC=C34)C)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3(OCC4=CC=CC=C34)C)C=C2)C=1)C CWJZWCRVEWUZAG-UHFFFAOYSA-N 0.000 description 1
- KUFBYTQYTSEBMD-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3(OCC4=CC=CC=C34)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3(OCC4=CC=CC=C34)C)C=C2)C=1)Cl KUFBYTQYTSEBMD-UHFFFAOYSA-N 0.000 description 1
- FGKLXDWIRXHPDM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC(C4=CC=CC=C34)(C)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC(C4=CC=CC=C34)(C)C)C=C2)C=1)Cl FGKLXDWIRXHPDM-UHFFFAOYSA-N 0.000 description 1
- KEWCSGQGTMJEHR-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C(=CC=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C(=CC=C4)F)C=C2)C=1)Cl KEWCSGQGTMJEHR-UHFFFAOYSA-N 0.000 description 1
- OEAQJQFNHMQDCC-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)C)C=C2)C=1)Cl OEAQJQFNHMQDCC-UHFFFAOYSA-N 0.000 description 1
- CYTSYAUVKCCCAF-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)F)C=C2)C=1)Cl CYTSYAUVKCCCAF-UHFFFAOYSA-N 0.000 description 1
- BWXMIBDLGJKSAK-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC(=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC(=C4)F)C=C2)C=1)Cl BWXMIBDLGJKSAK-UHFFFAOYSA-N 0.000 description 1
- QJTBOEMYDKQCOM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)C QJTBOEMYDKQCOM-UHFFFAOYSA-N 0.000 description 1
- SORWURQBSCSEJP-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl SORWURQBSCSEJP-UHFFFAOYSA-N 0.000 description 1
- CATGOURPAQRYOR-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)OC Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)OC CATGOURPAQRYOR-UHFFFAOYSA-N 0.000 description 1
- OMLBEQAVQZXNBE-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)C OMLBEQAVQZXNBE-UHFFFAOYSA-N 0.000 description 1
- MXFGXEDSHGDHMO-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-UHFFFAOYSA-N 0.000 description 1
- MXFGXEDSHGDHMO-QFIPXVFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-QFIPXVFZSA-N 0.000 description 1
- QJTBOEMYDKQCOM-QFIPXVFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)C QJTBOEMYDKQCOM-QFIPXVFZSA-N 0.000 description 1
- SORWURQBSCSEJP-FQEVSTJZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl SORWURQBSCSEJP-FQEVSTJZSA-N 0.000 description 1
- SAIGKYGQBCWHRO-HSZRJFAPSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)C)C=C2)C=1)Cl SAIGKYGQBCWHRO-HSZRJFAPSA-N 0.000 description 1
- JYDORGPQLIXHFE-JOCHJYFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)F)C=C2)C=1)Cl JYDORGPQLIXHFE-JOCHJYFZSA-N 0.000 description 1
- MXFGXEDSHGDHMO-JOCHJYFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-JOCHJYFZSA-N 0.000 description 1
- BIGVVTGYXZQHKR-UHFFFAOYSA-N BrCCC1OC2=C(C1)C=CC=C2 Chemical compound BrCCC1OC2=C(C1)C=CC=C2 BIGVVTGYXZQHKR-UHFFFAOYSA-N 0.000 description 1
- UKOHGWFAHLJCQH-PVSSEACSSA-N Br[C@H](CCC1=C(C=CC=C1)O)O.BrC[C@H]1OC2=C(C1)C=CC=C2 Chemical compound Br[C@H](CCC1=C(C=CC=C1)O)O.BrC[C@H]1OC2=C(C1)C=CC=C2 UKOHGWFAHLJCQH-PVSSEACSSA-N 0.000 description 1
- NBDBESBXUWNJLQ-UHFFFAOYSA-N C(=C)C1=C(C=O)C=CC=C1.CO Chemical compound C(=C)C1=C(C=O)C=CC=C1.CO NBDBESBXUWNJLQ-UHFFFAOYSA-N 0.000 description 1
- KXLPMZHJZRYUPP-UHFFFAOYSA-N C(C)(=O)OCC1=C(C=CC=C1)CC1=CC=CC=C1 Chemical compound C(C)(=O)OCC1=C(C=CC=C1)CC1=CC=CC=C1 KXLPMZHJZRYUPP-UHFFFAOYSA-N 0.000 description 1
- NQLGYKPQPDKDJE-UHFFFAOYSA-N C(C=C)C1=C(C=O)C=CC=C1.CO.C(C=C)C1=CC=CC=C1 Chemical compound C(C=C)C1=C(C=O)C=CC=C1.CO.C(C=C)C1=CC=CC=C1 NQLGYKPQPDKDJE-UHFFFAOYSA-N 0.000 description 1
- QOMCKHQJAWYXSL-UHFFFAOYSA-N CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)C Chemical compound CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)C QOMCKHQJAWYXSL-UHFFFAOYSA-N 0.000 description 1
- MILBLQYNLKWNKN-UHFFFAOYSA-N CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)Cl Chemical compound CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)Cl MILBLQYNLKWNKN-UHFFFAOYSA-N 0.000 description 1
- AWPDVVOQKIBNCR-UHFFFAOYSA-N CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)O.CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)OC Chemical compound CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)O.CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)OC AWPDVVOQKIBNCR-UHFFFAOYSA-N 0.000 description 1
- LHOHSRZIIUOSAN-UHFFFAOYSA-N CO.C(C=C)C1=CC=CC=C1.ClCC1=C(C=CC=C1)CC=C Chemical compound CO.C(C=C)C1=CC=CC=C1.ClCC1=C(C=CC=C1)CC=C LHOHSRZIIUOSAN-UHFFFAOYSA-N 0.000 description 1
- LZUVRDZXGRGVHU-UHFFFAOYSA-N COC1=C(C(=O)O)C=C(C=C1)Br.CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)O Chemical compound COC1=C(C(=O)O)C=C(C=C1)Br.CC(=O)C1=C(C=C(C=C1)F)C1=C(C=CC(=C1)Br)O LZUVRDZXGRGVHU-UHFFFAOYSA-N 0.000 description 1
- XTNGUQKDFGDXSJ-ZXGKGEBGSA-N Canagliflozin Chemical compound CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 XTNGUQKDFGDXSJ-ZXGKGEBGSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VMHWCCHWWNCLPQ-UHFFFAOYSA-N ClC1(C(COC(C1O)CO)(O)C1=C(C=C(C=C1)OCC1OC(C2=CC=CC=C12)(C)C)CC1=CC=CC=C1)O Chemical compound ClC1(C(COC(C1O)CO)(O)C1=C(C=C(C=C1)OCC1OC(C2=CC=CC=C12)(C)C)CC1=CC=CC=C1)O VMHWCCHWWNCLPQ-UHFFFAOYSA-N 0.000 description 1
- VTGAJDMLNBVTRF-SJZQLPTNSA-N ClC1=C(C=C(C=C1)C1(O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F Chemical compound ClC1=C(C=C(C=C1)C1(O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F VTGAJDMLNBVTRF-SJZQLPTNSA-N 0.000 description 1
- ZYPBQGOGPKQPFM-TWQRTPDCSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC(=C(C=C1)OCC1OC2=C(C1)C=CC=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC(=C(C=C1)OCC1OC2=C(C1)C=CC=C2)F ZYPBQGOGPKQPFM-TWQRTPDCSA-N 0.000 description 1
- DBRFXVYVLMFFSQ-TWQRTPDCSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C(=CC=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C(=CC=C2)F DBRFXVYVLMFFSQ-TWQRTPDCSA-N 0.000 description 1
- ZKCQEPKJMTVUPT-AQCDROMSSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)C ZKCQEPKJMTVUPT-AQCDROMSSA-N 0.000 description 1
- YLUOFFVBNMGJSO-QYENANPWSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)F YLUOFFVBNMGJSO-QYENANPWSA-N 0.000 description 1
- PVDJPDFLWJGBIA-QYENANPWSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC(=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC(=C2)F PVDJPDFLWJGBIA-QYENANPWSA-N 0.000 description 1
- SYOQMNCJSLHWIT-DFLSAPQXSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C(=CC=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C(=CC=C2)F SYOQMNCJSLHWIT-DFLSAPQXSA-N 0.000 description 1
- DBIFKCGYYMERAL-DFLSAPQXSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=C(C=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=C(C=C2)F DBIFKCGYYMERAL-DFLSAPQXSA-N 0.000 description 1
- JVLNUVUSJZRQKS-DFLSAPQXSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=CC(=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=CC(=C2)F JVLNUVUSJZRQKS-DFLSAPQXSA-N 0.000 description 1
- OLOATZAXGBXLGE-CBNWRBMVSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=CC=C2F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC=1OC2=C(C=1)C=CC=C2F OLOATZAXGBXLGE-CBNWRBMVSA-N 0.000 description 1
- RBEJDGYWSLUYEX-AQCDROMSSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCCC1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCCC1OC2=C(C1)C=CC=C2 RBEJDGYWSLUYEX-AQCDROMSSA-N 0.000 description 1
- MHDQPSWZICUHJJ-CJSXUKLZSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)C MHDQPSWZICUHJJ-CJSXUKLZSA-N 0.000 description 1
- PGBNOKIUOPBGKO-GTMDKHCLSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)F PGBNOKIUOPBGKO-GTMDKHCLSA-N 0.000 description 1
- MNTRDKUFKKJRNZ-UHFFFAOYSA-N ClCC1=C(C=CC=C1)CC=C.CC1(OCC2=CC=CC=C12)CO Chemical compound ClCC1=C(C=CC=C1)CC=C.CC1(OCC2=CC=CC=C12)CO MNTRDKUFKKJRNZ-UHFFFAOYSA-N 0.000 description 1
- JVZAZWKXHOJDCX-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C(=CC=C2)F Chemical compound ClCC=1OC2=C(C=1)C(=CC=C2)F JVZAZWKXHOJDCX-UHFFFAOYSA-N 0.000 description 1
- FWMZQFQQEMRXLU-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C=CC(=C2)F Chemical compound ClCC=1OC2=C(C=1)C=CC(=C2)F FWMZQFQQEMRXLU-UHFFFAOYSA-N 0.000 description 1
- IEHLSVIJVDOAKT-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C=CC=C2F Chemical compound ClCC=1OC2=C(C=1)C=CC=C2F IEHLSVIJVDOAKT-UHFFFAOYSA-N 0.000 description 1
- JWTSTOACXVSHNS-FYRLPREMSA-N ClCCl.O1C(CC2=C1C=CC=C2)COC2=CC=C(CC=1C=C(C=CC1C)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)C=C2 Chemical compound ClCCl.O1C(CC2=C1C=CC=C2)COC2=CC=C(CC=1C=C(C=CC1C)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)C=C2 JWTSTOACXVSHNS-FYRLPREMSA-N 0.000 description 1
- FLUWFVGRFVIMTA-UHFFFAOYSA-N ClS(=O)Cl.ClCC=1OC2=C(C1)C=C(C=C2)F Chemical compound ClS(=O)Cl.ClCC=1OC2=C(C1)C=C(C=C2)F FLUWFVGRFVIMTA-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- RECLUEYIMXGQLY-UHFFFAOYSA-N FC1=C(C=O)C(=CC=C1)OC1OCCCC1.FC1=C(C=O)C(=CC=C1)O Chemical compound FC1=C(C=O)C(=CC=C1)OC1OCCCC1.FC1=C(C=O)C(=CC=C1)O RECLUEYIMXGQLY-UHFFFAOYSA-N 0.000 description 1
- YVFFTHNBDJKNOL-UHFFFAOYSA-N FC=1C=C(C=CC1)C1OCCCC1.FC1=C(C=O)C(=CC=C1)OC1OCCCC1 Chemical compound FC=1C=C(C=CC1)C1OCCCC1.FC1=C(C=O)C(=CC=C1)OC1OCCCC1 YVFFTHNBDJKNOL-UHFFFAOYSA-N 0.000 description 1
- QKNRDEKOXUDPKO-UHFFFAOYSA-N FC=1C=C(C=CC1)O.FC=1C=C(C=CC1)C1OCCCC1 Chemical compound FC=1C=C(C=CC1)O.FC=1C=C(C=CC1)C1OCCCC1 QKNRDEKOXUDPKO-UHFFFAOYSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- LWQWDNDVPLPJCY-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=C(C=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1)F Chemical compound O1C(=CC2=C1C=CC=C2)COC1=C(C=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1)F LWQWDNDVPLPJCY-DFLSAPQXSA-N 0.000 description 1
- IPBHNTPOJRNPCZ-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 IPBHNTPOJRNPCZ-RQKPWJHBSA-N 0.000 description 1
- NIKWHNYNSIKYHY-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 NIKWHNYNSIKYHY-DFLSAPQXSA-N 0.000 description 1
- MEIZZXIIHFPBDY-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 MEIZZXIIHFPBDY-RQKPWJHBSA-N 0.000 description 1
- AYQMOLAIBRTRNL-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 AYQMOLAIBRTRNL-DFLSAPQXSA-N 0.000 description 1
- LYZBNSNBRSKCKG-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 LYZBNSNBRSKCKG-DFLSAPQXSA-N 0.000 description 1
- VYPKMXZMMOSMLR-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 VYPKMXZMMOSMLR-RQKPWJHBSA-N 0.000 description 1
- AVTUFMPWLUPALP-UHFFFAOYSA-N O1C(CC2=C1C=CC=C2)CCO.BrCCC2OC1=C(C2)C=CC=C1 Chemical compound O1C(CC2=C1C=CC=C2)CCO.BrCCC2OC1=C(C2)C=CC=C1 AVTUFMPWLUPALP-UHFFFAOYSA-N 0.000 description 1
- PUWUVKYKRLFQMR-CYDVYFGRSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 PUWUVKYKRLFQMR-CYDVYFGRSA-N 0.000 description 1
- XNNQAARVCUYAKW-RMFGLVLUSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 XNNQAARVCUYAKW-RMFGLVLUSA-N 0.000 description 1
- VYLYNQGAEQUOKU-QYENANPWSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 VYLYNQGAEQUOKU-QYENANPWSA-N 0.000 description 1
- GBOINAFCKBFJMU-AQCDROMSSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 GBOINAFCKBFJMU-AQCDROMSSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229940126902 Phlorizin Drugs 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 102000003673 Symporters Human genes 0.000 description 1
- 108090000088 Symporters Proteins 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- KDSYNTPPPISIJB-UHFFFAOYSA-N [3-[[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxymethyl]phenyl]-(3-fluoro-4-hydroxypyrrolidin-1-yl)methanone Chemical compound NCc1cc(OCc2cccc(c2)C(=O)N2CC(O)C(F)C2)nc(c1)C(F)(F)F KDSYNTPPPISIJB-UHFFFAOYSA-N 0.000 description 1
- SGVGVNPLNDXZTJ-KPQVYDHLSA-N [C@@H]1(OCC2=CC=CC=C12)CO[Si](C(C)C)(C(C)C)C(C)C.[C@@H]1(OCC2=CC=CC=C12)CO Chemical compound [C@@H]1(OCC2=CC=CC=C12)CO[Si](C(C)C)(C(C)C)C(C)C.[C@@H]1(OCC2=CC=CC=C12)CO SGVGVNPLNDXZTJ-KPQVYDHLSA-N 0.000 description 1
- SMFKZJJISKKNPX-UHFFFAOYSA-N [Na].O1C(=CC2=C1C=CC=C2)CO Chemical compound [Na].O1C(=CC2=C1C=CC=C2)CO SMFKZJJISKKNPX-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- UMIVXZPTRXBADB-UHFFFAOYSA-N benzocyclobutene Chemical compound C1=CC=C2CCC2=C1 UMIVXZPTRXBADB-UHFFFAOYSA-N 0.000 description 1
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- VAOPEQGLAIKHQE-UHFFFAOYSA-N bromobenzene formaldehyde Chemical compound C=O.BrC1=CC=CC=C1 VAOPEQGLAIKHQE-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-LSOMNZGLSA-N cinchonine Chemical compound C1=CC=C2C([C@@H]([C@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-LSOMNZGLSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 125000004431 deuterium atom Chemical group 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical class C1(C=CC2=CC=CC=C12)* 0.000 description 1
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000005438 isoindazolyl group Chemical group 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- ILHLLAOKTGOVCI-UHFFFAOYSA-N methanol prop-2-enylbenzene Chemical compound CO.C(C=C)C1=CC=CC=C1 ILHLLAOKTGOVCI-UHFFFAOYSA-N 0.000 description 1
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
- WZZMHOBVLAEJOD-UHFFFAOYSA-N methylsulfanylmethane;hydrobromide Chemical compound [Br-].C[SH+]C WZZMHOBVLAEJOD-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- GMBXBKNMMIWUED-UHFFFAOYSA-N n-(2,2,6,6-tetramethylpiperidin-4-yl)-3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]propanamide Chemical compound C1C(C)(C)NC(C)(C)CC1NCCC(=O)NC1CC(C)(C)NC(C)(C)C1 GMBXBKNMMIWUED-UHFFFAOYSA-N 0.000 description 1
- SVEUVITYHIHZQE-UHFFFAOYSA-N n-methylpyridin-2-amine Chemical compound CNC1=CC=CC=N1 SVEUVITYHIHZQE-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910021332 silicide Inorganic materials 0.000 description 1
- FVBUAEGBCNSCDD-UHFFFAOYSA-N silicide(4-) Chemical compound [Si-4] FVBUAEGBCNSCDD-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000004571 thiomorpholin-4-yl group Chemical group N1(CCSCC1)* 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 125000006168 tricyclic group Chemical group 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410148116.X | 2014-04-14 | ||
| CN201410148116 | 2014-04-14 | ||
| CN201410392098.X | 2014-08-11 | ||
| CN201410392098.XA CN105001213B (zh) | 2014-04-14 | 2014-08-11 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| PCT/CN2015/075651 WO2015158206A1 (zh) | 2014-04-14 | 2015-04-01 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511383A JP2017511383A (ja) | 2017-04-20 |
| JP2017511383A5 JP2017511383A5 (enExample) | 2018-05-17 |
| JP6577569B2 true JP6577569B2 (ja) | 2019-09-18 |
Family
ID=54323473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505695A Expired - Fee Related JP6577569B2 (ja) | 2014-04-14 | 2015-04-01 | C−アリールグリコシド誘導体、その薬物組成物、及び調製方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9914724B2 (enExample) |
| EP (1) | EP3133071B1 (enExample) |
| JP (1) | JP6577569B2 (enExample) |
| CN (1) | CN105001213B (enExample) |
| WO (1) | WO2015158206A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105001213B (zh) | 2014-04-14 | 2020-08-28 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN105017236A (zh) * | 2014-04-14 | 2015-11-04 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| TN2018000020A1 (en) * | 2015-07-20 | 2019-07-08 | Genzyme Corp | Colony stimulating factor-1 receptor (csf-1r) inhibitors. |
| CN106892948B (zh) * | 2015-12-17 | 2022-07-26 | 宜昌东阳光长江药业股份有限公司 | 吡喃葡萄糖基衍生物及其在医药上的应用 |
| CN106928040A (zh) * | 2015-12-31 | 2017-07-07 | 上海医药工业研究院 | Sglt2抑制剂中间体的制备方法 |
| CN107720781B (zh) * | 2017-11-30 | 2018-07-17 | 五莲森之林海藻有限公司 | 一种盐晶颗粒提取设备 |
| CN111465598B (zh) * | 2018-03-30 | 2023-04-21 | 山东丹红制药有限公司 | 作为SGLTs抑制剂的葡糖苷类衍生物及其应用 |
| CN111471031B (zh) * | 2019-01-24 | 2023-05-16 | 北京盈科瑞创新药物研究有限公司 | 一种糖苷类衍生物及其制备方法和应用 |
| CN111471032B (zh) * | 2019-01-24 | 2023-08-01 | 北京盈科瑞创新药物研究有限公司 | 一种糖苷类衍生物的合成方法及其中间体和应用 |
| CN114585358B (zh) * | 2019-07-26 | 2023-11-10 | 东宝紫星(杭州)生物医药有限公司 | 一种SGLTs/DPP4抑制剂及其应用 |
| CN111269205B (zh) * | 2020-02-19 | 2023-05-26 | 华侨大学 | 一种c-芳基糖苷化合物的制备方法 |
| CN112961196B (zh) * | 2021-02-07 | 2022-05-31 | 中国人民大学 | 一种糖基和多肽修饰的1,2,3-三唑化合物的制备方法 |
| CN115991702B (zh) * | 2021-12-09 | 2024-02-02 | 珠海市藤栢医药有限公司 | 芳基c-葡萄糖苷衍生物、其制备方法及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12000002657B1 (en) * | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| US6683056B2 (en) * | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
| US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| JP2004536047A (ja) | 2001-04-11 | 2004-12-02 | ブリストル−マイヤーズ スクイブ カンパニー | 糖尿病処置用c−アリールグルコシドのアミノ酸複合体および方法 |
| CA2512389A1 (en) | 2003-01-03 | 2004-07-29 | Bristol-Myers Squibb Company | Methods of producing c-aryl glucoside sglt2 inhibitors |
| ES2363941T3 (es) * | 2003-03-14 | 2011-08-19 | Astellas Pharma Inc. | Derivados de c-glucósido para el tratamiento de diabetes. |
| ES2649737T5 (es) | 2003-08-01 | 2021-07-07 | Mitsubishi Tanabe Pharma Corp | Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio |
| CN103030617A (zh) * | 2004-03-16 | 2013-04-10 | 贝林格尔.英格海姆国际有限公司 | 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法 |
| JP5238492B2 (ja) * | 2005-04-15 | 2013-07-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Sgltインヒビターとしてのグルコピラノシル置換(ヘテロアリールオキシ−ベンジル)−ベンゼン誘導体 |
| BR112012008924A2 (pt) | 2009-10-20 | 2019-09-24 | Novartis Ag | derivado de glicosídeo e usos do mesmo |
| WO2012025857A1 (en) * | 2010-08-23 | 2012-03-01 | Hetero Research Foundation | Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors |
| CN102453026A (zh) * | 2010-10-27 | 2012-05-16 | 上海艾力斯医药科技有限公司 | C-芳基葡糖苷衍生物、制备方法及其应用 |
| JP6105489B2 (ja) * | 2011-02-18 | 2017-03-29 | シャンハイ インリ ファーマシューティカル カンパニー リミティド | アリールグルコシド化合物、その調製方法及び使用 |
| US9562029B2 (en) * | 2011-06-25 | 2017-02-07 | Xuanzhu Pharma Co., Ltd. | C-glycoside derivatives |
| CN104059042B (zh) | 2013-03-22 | 2017-02-08 | 正大天晴药业集团股份有限公司 | C-三芳基葡萄糖苷类sglt-2抑制剂 |
| CN105017236A (zh) | 2014-04-14 | 2015-11-04 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN105001213B (zh) | 2014-04-14 | 2020-08-28 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
-
2014
- 2014-08-11 CN CN201410392098.XA patent/CN105001213B/zh active Active
-
2015
- 2015-04-01 EP EP15780125.9A patent/EP3133071B1/en active Active
- 2015-04-01 JP JP2017505695A patent/JP6577569B2/ja not_active Expired - Fee Related
- 2015-04-01 US US15/304,493 patent/US9914724B2/en not_active Expired - Fee Related
- 2015-04-01 WO PCT/CN2015/075651 patent/WO2015158206A1/zh not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3133071A1 (en) | 2017-02-22 |
| US20170037038A1 (en) | 2017-02-09 |
| JP2017511383A (ja) | 2017-04-20 |
| CN105001213A (zh) | 2015-10-28 |
| EP3133071A4 (en) | 2017-02-22 |
| US9914724B2 (en) | 2018-03-13 |
| WO2015158206A1 (zh) | 2015-10-22 |
| EP3133071B1 (en) | 2019-12-18 |
| CN105001213B (zh) | 2020-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6577569B2 (ja) | C−アリールグリコシド誘導体、その薬物組成物、及び調製方法 | |
| JP4456768B2 (ja) | C−配糖体を含有する薬剤 | |
| TWI457122B (zh) | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3-二氫苯並[1,4]戴奧辛-2-基甲基衍生物 | |
| CN104870429B (zh) | 苯并呋喃衍生物、其制备方法及其在医药上的应用 | |
| TWI477497B (zh) | 苯并呋喃衍生物 | |
| US12286430B2 (en) | Bcl-2 inhibitor | |
| TW201103535A (en) | Carboxylic acid compounds | |
| CN104507921B (zh) | 苯并环丁烯类衍生物、其制备方法及其在医药上的应用 | |
| WO2013104257A1 (zh) | 多环类衍生物、其制备方法及其在医药上的应用 | |
| JP2024517326A (ja) | レゾルシノール類、それら製造のための方法、及びその使用 | |
| KR102580087B1 (ko) | 자가포식 조절인자(autophagy regulator)로서 사용된 화합물, 및 이에 대한 제조 방법 및 이의 용도 | |
| CN111566102B (zh) | 作为激活素受体样激酶抑制剂的取代的吡咯并吡啶 | |
| TWI329013B (en) | Cannabinoid receptor modulator | |
| TW200306813A (en) | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | |
| CN105017236A (zh) | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 | |
| WO2020224396A1 (zh) | 抑制tdg活性的化合物 | |
| CN110418790B (zh) | 作为p53-MDM2抑制剂的咪唑并吡咯酮化合物 | |
| CN109824690A (zh) | Mcl-1选择性抑制剂及其制备和用途 | |
| JP4304732B2 (ja) | エストロゲンレセプターβアイソフォーム活性化剤 | |
| JPH05178850A (ja) | ベンゾピラン誘導体、その製法および血圧降下剤 | |
| KR20090101275A (ko) | 벤조퀴나졸 유도체 | |
| WO2024230586A1 (zh) | 含二氮杂亚基磺酰结构的化合物作为pkm2激动剂的新用途 | |
| KR20250101906A (ko) | 아라비노스 유도체 화합물 및 이를 포함하는 퇴행성 뇌질환 예방용 또는 치료용 조성물 | |
| KR20250108069A (ko) | 아라비노스 유도체 화합물 및 이를 포함하는 퇴행성 뇌질환 예방용 또는 치료용 조성물 | |
| WO2024245143A1 (zh) | 含二氮杂亚基磺酰结构化合物的药物组合物在治疗贫血相关疾病中的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180326 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180326 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181220 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190415 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190730 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190822 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6577569 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |